<sup>177</sup>Lu‐PSMA radioligand therapy effectiveness in metastatic castration‐resistant prostate cancer: An updated systematic review and meta‐analysis

202246 citationsReviewgreen Open Access

Authors

Mohammad Salehi Sadaghiani · Johns Hopkins University

Sara Sheikhbahaei · Johns Hopkins University

Rudolf A. Werner · Universitätsklinikum Würzburg

Kenneth J. Pienta · Johns Hopkins University

Martin G. Pomper · Johns Hopkins University

Michael A. Gorin · University of Pittsburgh

Lilja B. Sólnes

Abstract

This is the first meta-analysis to aggregate the recent randomized controlled trials of PRLT which shows CRPC patients had a higher response to therapy after PRLT compared to controls.

Topics & Keywords

Prostate Cancer Treatment and Research Radiopharmaceutical Chemistry and Applications Peptidase Inhibition and Analysis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The Prostate

Volume 82, Issue 7, pp. 826-835

DOI: 10.1002/pros.24325

Field-Weighted Citation Impact: 6.84